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Several drugs are being used in treatment of HSV (Herpesviridae) infection in human but still 
introducing an effective safe drug is desirable. We investigated the inhibitory effect of morphine on 
replication of HSV in vitro. The results indicated that a concentration of up to 200 µg/ml morphine had a 
limited effect on Vero cell viability. At this concentration, the growth of HSV was inhibited considerably 
and after the third passage in presence of morphine it was completely eliminated. The presence of viral 
antigens in infected cells in presence of morphine by immunoflourescent staining showed that after the 
first passage a small number of infected cells contained viral proteins and at the third passage no cells 
with viral antigen was observed. This was confirmed by page and immunobloting techniques. Electron 
microscopy observation in cellular section indicated that there was no virus present in treated cells as 
compared with control untreated infected cells. 
 





Herpes simplex virus type 1 and 2 belongs to -
herpesvirinae subfamily of Herpesviridae family. HSV 
virus genome has a double strand DNA which codes over 
70 gene products. HSV infection is the most common 
viral infections in human and causes an extended range 
of diseases (Roizman et al., 1974; Cleator and Klapper, 
2000; Roizman and Knipe, 2001). There are several 
antiviral drugs which are effective against HSV infections, 
and most of them inhibit viral DNA synthesis. Recently, 
physicians and researchers have been faced with the 
problem of elongated treatment with Acyclovir due to 
formation of drug resistant mutants and toxicity of the 
drug (Chatis and Crompacker, 1992; Schinazi et al., 
1982; Venard et al., 2001; Morfin et al., 2003). However, 
resistance has been reported, mainly among immuno-
compromised patients (prevalence around 5%) and 
particularly allogeneic bone marrow transplant patients 
(prevalence reaching 30%). Resistance to ACV is asso-
ciated with mutations on one of the two viral enzymes 
involved in the ACV activation: thymidine kinase (TK) and 
DNA polymerase (Crumpacker et al., 2001; Neyts et al., 
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with a mutation in the TK gene as this enzyme is not 
essential for viral replication, unlike viral DNA poly-
merase. It seems that an alternative method of treatment 
HSV infection by using a new effective drug is in demand 
(Chibo et al., 2004; Stránská et al., 2004). It has been 
shown that Morphine has the potential in preventing HSV 
pathogenesis in certain laboratory animals. The main 
objective of this study was to determine the inhibitory 
effect of morphine on HSV replication and growth in vitro 




MATERIALS AND METHODS 
 
Cell culture and virus 
 
Vero cells were grown in disposable plastic dishes or in 24 well 
plates and incubated in Dulbeccos Modified Eagles (DMEM) 
supplemented with 8% fetal bovine serum (FBS), 100 IU/ml of 
penicillin and 100 µg/ml of streptomycin. Herpes simplex virus type 
1 (HSV-1) was isolated from a patient and identified by specific 





Virus titration was performed by both TCID50 and plaque assay 
procedures. For TCID50, cells were grown in 24 wells tissue culture 
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Figure 1. Effect of morphine on viability of Vero cells. 
The high absorbancy represents more uptake of neutral 




dishes and the test was performed according to the Reid and 
Muntch method. For plaque assay, monolayer of Vero cells were 
grown in 24 wells tissue culture dishes and were infected with serial 
dilutions of HSV virus. The infected monolayer were overlaid and 
incubated at 37°C for 72 h. A second overlay containing 0.1% neu-
tral red was used and plaques were counted after 12 h. 
 
 
Determination of morphine cytotoxicity 
 
Cytotoxicity was evaluated by the neutral red staining (NRS) 
method and examined by the growth inhibition of Vero cells. Briefly, 
Vero cells were grown in 24-well plates. After formation of complete 
monolayer, the culture medium was replaced by similar medium 
containing various concentration of morphine. After 4 days incuba-
tion at 4°C, 100 µl of 120 µg/ml of neutral red was added to each 
cell monolayer and incubated for 3 h at 37°C. After that the cells 
were washed with 0.5% formaldehyde containing 1% CaCl2. The 
cells were extracted in citrate-ethanol buffer for 1 h at 4°C. The 





For animal immunization, purified virus was required. HSV was 
purified on sucrose cushion followed by sucrose gradient 
centrifugation. Discontinuous sucrose gradient was formed by 
successive layering of 50, 40, 30, 20% sucrose (made up in 0.01 M 
Tris buffer). These gradients were then centrifuged at 18000 
rpm/min for 2 h using TST28.38 rotor. The virus bond was 




Preparation of specific antiserum 
 
Purified virus was mixed with Freund`s adjuvant and used to 
inoculate female New Zealand white rabbits. Three injections were 
given at weekly intervals and the last booster was given three 
weeks later. Rabbits were bled 10 days after the last injection and 
sera were separated and kept at -70°C until used (Eberle et al., 
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in infected cells. For immunoflourescence, cells were grown in 
monolayer on glass cover slip in 24-wells tissue culture dish and 
infected with HSV. 16 h post infection, cover slips were removed, 
washed in PBS and fixed in acetone at 4°C. They were stained 






Cells in monolayer were infected with HSV and fixed in 3% 
glutaraldehyde at 4°C for 3 h, then post fixed in 1% osmium 
tetroxide. After dehydration in serial dilutions of ethanol, they were 
embedded in araldite. Sections were cut, stained with uranyl 
acetate followed by lead citrate. Negative staining of virus particles 





The optimum concentration of morphine which was non 
toxic for Vero cells was determined using neutral red 
uptake in presence of various amount of morphine 
(Figure 1). It was found that concentration of 200 µg/ml 
was non toxic to Vero cells. The concentration used for 
HSV infected cells did not exceed 150 µg/ml. 
 
 
Effect of morphine on virus yield 
 
Antiviral effects of morphine was determined by addition 
of various amounts of morphine (below the toxic dose) to 
the HSV infected cells after the time of adsorption and 
the amount of infectious virus produced after 48 h was 
determined by both TCID50 and plaque assay methods. 
As it is shown in Figure 2, the titer of virus produced in 
presence of morphine was reduced to logs but the virus 
growth was not inhibited completely. After the third pass-
age in presence of morphine virus production was 
completely inhibited (Figure 2). The inhibitory effect of 
morphine was the highest till 4 h post infection and was 







Figure 3. Percent of infected cells containing HSV 
antigen after different passages. Cells were infect with 
the harvest of morphine treated infected cells at different 
passages infect cells were stained with immuno-






Figure 4. Effect of morphine on Viral DNA 
synthesis. Lane 1, marker; Lane 2, positive 
control; Lane 3, first passage; Lane 4, third 




Viral antigen in morphine treated cells 
 
To determine presence of viral antigens synthesized in 
presence of morphine, infected cells 16 h post infection 
were fixed and stained with anti HSV fluorescent 
conjugate. As shown in Figure 3, at the first passage 
most of infected cells lacked viral antigens as compared 
with control infected cells untreated with morphine. Only 
a small number of cells showed fluorescence in the first 
passage and in the third passage there was no HSV 
antigen in morphine treated cells (Figure 3). 
 
 
Viral DNA synthesis 
 
To determine presence of viral DNA in  morphine  treated 






Figure 5a. Electron micrograph of morphine treated 
infected cells in presence of naloxone showing HSV-






Figure 5b. Electron micrograph of morphine treated 




infected cells, DNA was extracted from cells and PCR 
test was performed using HSV-1 specific primers. 
Although DNA was detected in morphine treated cells at 
the first passage (Figure 4, lane 3) there was no detect-
able DNA after the third passage (Figure 4, lane 4). 
 
 
Electron microscopy of morphine treated cells 
 
Infected cells in presence of morphine lacked any detect-
able virus particles as compared with the control untreat-
ed cells indicating that there was no virus replication in 






It has been reported that morphine could prevent patho-
genesis of HSV in mice and reduces mortality following 
ocular infection with HSV-1 (Weeks et al., 2001; Alonzo 
and Carr, 1999; Lioy et al., 2005; Packman et al., 1976). 
We investigated the inhibitory effect of morphine on 
growth and replication of HSV in Vero cells. The first step 
was to determine the concentration of morphine which 
did not affect the viability of uninfected Vero cells. The 
viability of cell in presence of  morphine  was  determined 




by the uptake of neutral red which is a vital dye and is 
taken up by live cells (Moattari et al., 2002). Using the 
nontoxic concentration of morphine, it was found that 
morphine inhibited replication of HSV in Vero cells. 
However, at first passage, there were some detectable 
virus particles in infected cells which completely 
disappeared in third passage. The reason for complete 
inhibition of viral growth is not clear. It is possible that the 
inhibitory effect of morphine was dose dependent. In the 
second passage when virus titer was low the inhibition 
was complete. The absence of viral DNA as was 
determined by PCR and the lack of viral protein synthesis 
indicated that the inhibition effect was not due to the 
prevention of viral assembly (Cone and Hobson, 1991).  
Although the mechanism of HSV growth inhibition of 
morphine is not clear it seems that the inhibition is due to 
prevention of viral macromolecular synthesis. Morphine 
inhibited the growth of both HSV-1 and HSV-2. The 
inhibitory effect was very similar for both viruses. We did 
not test the growth inhibition of other herpes viruses. It 
would be interesting to investigate the effect of morphine 
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